Combination of conventional chemotherapeutics with redox-active cerium oxide nanoparticles - A novel aspect in cancer therapy

Molecular Cancer Therapeutics

Volumn 13, Issue 7, 2014, Pages 1740-1749

  Sack, Maren ^a   Alili, Lirija ^a   Karaman, Elif ^a   Das, Soumen ^b   Gupta, Ankur ^b   Seal, Sudipta ^b   Brenneisen, Peter ^a  

^a Department of Orthopedic Surgery   (Germany)

^b UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; CERIUM OXIDE; CERIUM OXIDE NANOPARTICLE; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; FLUORESCEIN ISOTHIOCYANATE; FLUORESCENT DYE; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; SULFENIC ACID DERIVATIVE; UNCLASSIFIED DRUG; CERIC OXIDE; CERIUM;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CELL DAMAGE; CELL PROTECTION; CELL VIABILITY; CELLULAR DISTRIBUTION; COMET ASSAY; COMPLEX FORMATION; DNA DAMAGE; DNA REPLICATION; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG POTENTIATION; DRUG UPTAKE; ENZYME ACTIVITY; FEMALE; GENOTOXICITY; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MELANOMA CELL LINE; METASTASIS; OXIDATION REDUCTION REACTION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN MODIFICATION; SKIN TUMOR; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WESTERN BLOTTING; CHEMISTRY; METABOLISM; MIDDLE AGED; NANOTECHNOLOGY; PROCEDURES; SKIN NEOPLASMS; TUMOR CELL LINE;

CELL LINE, TUMOR; CERIUM; DOXORUBICIN; FEMALE; HUMANS; MELANOMA; MIDDLE AGED; NANOPARTICLES; NANOTECHNOLOGY; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SKIN NEOPLASMS;

EID: 84904209549     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-13-0950     Document Type: Article

References (40)

1. Sahoo SK, Parveen S, Panda JJ. The present and future of nanotechnology in human health care. Nanomedicine 2007;3:20-31. (Pubitemid 46428187)
2. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007;2:751-60. (Pubitemid 350223348)
3. Florence AT. "Targeting" nanoparticles: the constraints of physical laws and physical barriers. J Control Release 2012;64:115-24.
4. Jain KK. Advances in the field of nanooncology. BMC Med 2010;8:83.
5. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
6. Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol 2009;27:3-9.
7. Lin W, Huang YW, Zhou XD, Ma Y. Toxicity of cerium oxide nanoparticles in human lung cancer cells. Int J Toxicol 2006;25:451-7. (Pubitemid 44885100)
8. Eom HJ, Choi J. Oxidative stress of CeO2 nanoparticles via p38-Nrf-2 signaling pathway in human bronchial epithelial cell, Beas-2B. Toxicol Lett 2009;187:77-83.
9. Perez JM, Asati A, Nath S, Kaittanis C. Synthesis of biocompatible dextran-coated nanoceria with pH-dependent antioxidant properties. Small 2008;4:552-6. (Pubitemid 351808047)
10. Chen J, Patil S, Seal S, McGinnis JF. Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat Nanotechnol 2006;1:142-50.
11. Tarnuzzer RW, Colon J, Patil S, Seal S. Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. Nano Lett 2005;5:2573-7. (Pubitemid 43088915)
12. Alili L, Sack M, Karakoti AS, Teuber S, Puschmann K, Hirst SM, et al. Combined cytotoxic and anti-invasive properties of redox-active nanoparticles in tumor-stroma interactions. Biomaterials 2011;32:2918-29.
13. Alili L, Sack M, von Montfort C, Giri S, Das S, Carroll KS, et al. Downregulation of tumor growth and invasion by redox-active nanoparticles. Antioxid Redox Signal 2013;19:765-78.
14. Denko NC. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer 2008;8:705-13.
15. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004;4:891-9. (Pubitemid 39472955)
16. Kuphal S, Winklmeier A, Warnecke C, Bosserhoff AK. Constitutive HIF-1 activity in malignant melanoma. Eur J Cancer 2010;46:1159-69.
17. Lechner D, Weltermann A. [Pathophysiology of chemotherapy-associated thrombosis]. Hamostaseologie 2009;29:112-20.
18. Perrino C, Schiattarella GG, Magliulo F, Ilardi F, Carotenuto G, Gargiulo G, et al. Cardiac side effects of chemotherapy: state of art and strategies for a correct management. Curr Vascu Pharmacol 2012;12:106-16.
19. Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 2004;56:185-229. (Pubitemid 38720829)
20. Du C, Deng D, Shan L, Wan S, Cao J, Tian J, et al. A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery. Biomaterials 2013;34:3087-97.
21. Seo YH, Carroll KS. Profiling protein thiol oxidation in tumor cells using sulfenic acid-specific antibodies. Proc Natl Acad Sci U S A 2009; 106:16163-8.
22. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 1973;51:1417-23.
23. Bayreuther K, Francz PI, Gogol J, Kontermann K. Terminal differentiation, aging, apoptosis, and spontaneous transformation in fibroblast stem cell systems in vivo and in vitro. Ann NY Acad Sci 1992;663:167-79. (Pubitemid 23090535)
24. Stuhlmann D, Ale-Agha N, Reinehr R, Steinbrenner H, Ramos MC, Sies H, et al. Modulation of homologous gap junctional intercellular communication of human dermal fibroblasts via a paracrine factor(s) generated by squamous tumor cells. Carcinogenesis 2003;24:1737-48. (Pubitemid 37408136)
25. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63. (Pubitemid 14203433)
26. Karakoti AS, Kuchibhatla SVNT, Babu KS, Seal S. Direct synthesis of nanoceria in aqueous polyhydroxyl solutions. J Phys Chem C 2007;111:17232-40. (Pubitemid 350258366)
27. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
28. Singh NP, Stephens RE, Schneider EL. Modifications of alkaline microgel electrophoresis for sensitive detection of DNA damage. Int J Radiat Biol 1994;66:23-8. (Pubitemid 24231348)
29. Albrecht C, Borm PJ, Unfried K. Signal transduction pathways relevant for neoplastic effects of fibrous and non-fibrous particles. Mutat Res 2004;553:23-35. (Pubitemid 38993720)
30. Woodward WA, Strom EA, McNeese MD, Perkins GH, Outlaw EL, Hortobagyi GN, et al. Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicinbased chemotherapy. Int J Radiat Oncol Biol Phys 2003;57:327-35. (Pubitemid 37040927)
31. Park EJ, Choi J, Park YK, Park K. Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells. Toxicology 2008;245:90-100.
32. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 2003;329:23-38. (Pubitemid 36187411)
33. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A. Protein carbonylation in human diseases. Trends Mol Med 2003;9:169-76. (Pubitemid 36626706)
34. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000;21:361-70. (Pubitemid 30137921)
35. Bawarski WE, Chidlowsky E, Bharali DJ, Mousa SA. Emerging nanopharmaceuticals. Nanomedicine 2008;4:273-82.
36. Cho K, Wang X, Nie S, Chen ZG, Shin DM. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008;14:1310 -6.
37. Heckert EG, Karakoti AS, Seal S, Self WT. The role of cerium redox state in the SOD mimetic activity of nanoceria. Biomaterials 2008;29:2705-9.
38. Smylie MG, Wong R, Mihalcioiu C, Lee C, Pouliot JF. A phase II, open label, monotherapy study of liposomal doxorubicin in patients with metastatic malignant melanoma. Invest New Drugs 2007;25:155-9. (Pubitemid 46020874)
39. Mishina NM, Tyurin-Kuzmin PA, Markvicheva KN, Vorotnikov AV, Tkachuk VA, Laketa V, et al. Does cellular hydrogen peroxide diffuse or act locally? Antioxid Redox Signal 2011;14:1-7.
40. De Marzi L, Monaco A, De Lapuente J, Ramos D, Borras M, Di Gioacchino M, et al. Cytotoxicity and genotoxicity of ceria nanoparticles on different cell lines in vitro. Int J Mol Sci 2013;14:3065-77.